OVID
Ovid Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.80
+0.72%Margins
Gross margin
100.0%
EBITDA margin
-2252.4%
EBIT margin
-3686.7%
Net margin
-2178.9%
FCF margin
-3460.1%
-16.4%
Return on equity
-14.9%
Return on assets
-26.2%
Return on invested capital
0.01x
Asset turnover
-$54.8M
Cash from operations
$0.60
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026